Researchers at the University of California-San Francisco (UCSF) have restored to normal levels a key protein that is involved in early brain development, and is linked to the rare brain disorder lissencephaly.
Reduced levels of the protein called LIS1 have been shown to cause lissencephaly, which is characterized by brain malformations, seizures, severe mental retardation and very early death in human infants.
Head Injury
Head injury or traumatic brain injury is a leading cause of disability among children and young adults that leads to varying degrees of physical and mental stability. Fortunately, it is also one of the preventable brain disorder.
Advertisement
The findings in mice offer a proof-of-principle that the genetic equivalent to human lissencephaly, also known as "smooth brain" disease, can be treated during pregnancy and effectively reversed to produce more normal offspring.
The researchers are hoping that this approach could also be used to treat other defects in utero, or even those manifesting after birth, when caused by a partial deficiency in one gene, according to Dr. Anthony Wynshaw-Boris.
![Brain Tumor]( "Brain Tumor")
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.
"Researchers have not considered it possible to treat such a pervasive, early developmental brain disorder as lissencephaly. Not only were we able to show a clear cellular effect from using these protease inhibitors, but also were able to treat the disorder in utero," Nature quoted Wynshaw-Boris as saying.
The work is the culmination of 15 years of collaborative research into the cause and mechanisms of lissencephaly, which is caused by a deletion or loss of one copy of the LIS1 gene, and affects an estimated one in 50,000-100,000 infants.
In 1998, the researchers reported of producing a mouse with the same mutation that displayed defective brain development.
The current research used these mice, and found that the protein calpain degrades the LIS1 protein to less than half its normal levels near the surface of the cells.
The team then used a specific small-molecule protease inhibitor of calpain in these mice.
At a cellular level, the protease inhibitors enabled LIS1 protein to be expressed at near-normal levels.
The team then gave daily injections of a calpain inhibitor to pregnant mice whose foetuses had the mouse-model of this defect.
They observed that the resulting offspring had more normal brains and showed no sign of mental retardation.
"This study is really a proof-of-principle not only for treating complex developmental brain disorders, but also for any disorder with reduced protein levels where proteases normally play some role in breaking down that protein. This will be much more difficult to apply to humans, because of the safety issues involved, but it could lead to new therapies that might be effective for a wide range of developmental disorders," said the researchers.
The findings have been published in the journal Nature Medicine.
Source: ANI
RAS
Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.
Advertisement
"Researchers have not considered it possible to treat such a pervasive, early developmental brain disorder as lissencephaly. Not only were we able to show a clear cellular effect from using these protease inhibitors, but also were able to treat the disorder in utero," Nature quoted Wynshaw-Boris as saying.
The work is the culmination of 15 years of collaborative research into the cause and mechanisms of lissencephaly, which is caused by a deletion or loss of one copy of the LIS1 gene, and affects an estimated one in 50,000-100,000 infants.
In 1998, the researchers reported of producing a mouse with the same mutation that displayed defective brain development.
The current research used these mice, and found that the protein calpain degrades the LIS1 protein to less than half its normal levels near the surface of the cells.
The team then used a specific small-molecule protease inhibitor of calpain in these mice.
At a cellular level, the protease inhibitors enabled LIS1 protein to be expressed at near-normal levels.
The team then gave daily injections of a calpain inhibitor to pregnant mice whose foetuses had the mouse-model of this defect.
They observed that the resulting offspring had more normal brains and showed no sign of mental retardation.
"This study is really a proof-of-principle not only for treating complex developmental brain disorders, but also for any disorder with reduced protein levels where proteases normally play some role in breaking down that protein. This will be much more difficult to apply to humans, because of the safety issues involved, but it could lead to new therapies that might be effective for a wide range of developmental disorders," said the researchers.
The findings have been published in the journal Nature Medicine.
Source: ANI
RAS
Brilliant Human Brain - Animation
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.
Advertisement
 Brain Depression - AnimationInteractive section of Medindia provides information about chemistry of Brain depression | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Researchers found that treatments helping to repair nerve damage in neurons in a near-embryonic state might potentially restore sight and movement.
Tobacco smoke contains toxic chemicals which damage lungs, weaken the immune system and cause tuberculosis.
Identifying an unappreciated relationship between brain shape and activity overturns the century-old paradigm emphasizing the importance of complex brain connectivity.
Decoding the eight factors affecting Black adults' life expectancy.
Sobering truth about foot travel in the United States emerges from international statistics, highlighting the prevalence of walking on the Blacksburg campus.